Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
 - 
                            
PHILADELPHIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The...
 - 
                            
PHILADELPHIA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
 - 
                            
PHILADELPHIA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
 - 
                            
PHILADELPHIA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of...
 - 
                            
PHILADELPHIA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- CS Disco Inc. (NYSE: LAW) – Securities Fraud Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
 - 
                            
PHILADELPHIA, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
 - 
                            
PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Baxter International Inc. (NYSE: BAX): Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. (NYSE:...
 - 
                            
PHILADELPHIA, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
 - 
                            
PHILADELPHIA, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...